555 related articles for article (PubMed ID: 29367247)
21. Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth.
Maruo S; Johannsen E; Illanes D; Cooper A; Kieff E
J Virol; 2003 Oct; 77(19):10437-47. PubMed ID: 12970429
[TBL] [Abstract][Full Text] [Related]
22. Regulation of B cell receptor signalling by Epstein-Barr virus nuclear antigens.
Khasnis S; Veenstra H; McClellan MJ; Ojeniyi O; Wood CD; West MJ
Biochem J; 2022 Dec; 479(23):2395-2417. PubMed ID: 36383217
[TBL] [Abstract][Full Text] [Related]
23. An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A.
Lee W; Hwang YH; Lee SK; Subramanian C; Robertson ES
J Virol; 2001 Sep; 75(18):8556-68. PubMed ID: 11507201
[TBL] [Abstract][Full Text] [Related]
24. The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.
Banerjee S; Lu J; Cai Q; Saha A; Jha HC; Dzeng RK; Robertson ES
PLoS Pathog; 2013; 9(5):e1003314. PubMed ID: 23658517
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.
Cai Q; Guo Y; Xiao B; Banerjee S; Saha A; Lu J; Glisovic T; Robertson ES
PLoS Pathog; 2011 Dec; 7(12):e1002418. PubMed ID: 22174681
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.
Maruo S; Wu Y; Ishikawa S; Kanda T; Iwakiri D; Takada K
Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19500-5. PubMed ID: 17159137
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr Virus Facilitates Expression of KLF14 by Regulating the Cooperative Binding of the E2F-Rb-HDAC Complex in Latent Infection.
Pei Y; Wong JH; Jha HC; Tian T; Wei Z; Robertson ES
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847849
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus nuclear antigen 3C (EBNA3C) interacts with the metabolism sensing C-terminal binding protein (CtBP) repressor to upregulate host genes.
Ohashi M; Hayes M; McChesney K; Johannsen E
PLoS Pathog; 2021 Mar; 17(3):e1009419. PubMed ID: 33720992
[TBL] [Abstract][Full Text] [Related]
29. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
Faumont N; Durand-Panteix S; Schlee M; Grömminger S; Schuhmacher M; Hölzel M; Laux G; Mailhammer R; Rosenwald A; Staudt LM; Bornkamm GW; Feuillard J
J Virol; 2009 May; 83(10):5014-27. PubMed ID: 19264782
[TBL] [Abstract][Full Text] [Related]
30. Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha.
Cotter MA; Robertson ES
Mol Cell Biol; 2000 Aug; 20(15):5722-35. PubMed ID: 10891508
[TBL] [Abstract][Full Text] [Related]
31. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
Price AM; Messinger JE; Luftig MA
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
[TBL] [Abstract][Full Text] [Related]
32. BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV.
Paschos K; Parker GA; Watanatanasup E; White RE; Allday MJ
Nucleic Acids Res; 2012 Aug; 40(15):7233-46. PubMed ID: 22584624
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.
Pei Y; Singh RK; Shukla SK; Lang F; Zhang S; Robertson ES
J Virol; 2018 Sep; 92(18):. PubMed ID: 29997218
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.
Wang C; Zhou H; Xue Y; Liang J; Narita Y; Gerdt C; Zheng AY; Jiang R; Trudeau S; Peng CW; Gewurz BE; Zhao B
J Virol; 2018 May; 92(9):. PubMed ID: 29467311
[TBL] [Abstract][Full Text] [Related]
35. Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway.
Gain C; Malik S; Bhattacharjee S; Ghosh A; Robertson ES; Das BB; Saha A
PLoS Pathog; 2020 Feb; 16(2):e1008105. PubMed ID: 32092124
[TBL] [Abstract][Full Text] [Related]
36. Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells.
Wood CD; Carvell T; Gunnell A; Ojeniyi OO; Osborne C; West MJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021904
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa.
Bourillot PY; Waltzer L; Sergeant A; Manet E
J Gen Virol; 1998 Feb; 79 ( Pt 2)():363-70. PubMed ID: 9472621
[TBL] [Abstract][Full Text] [Related]
38. The Epstein-Barr Virus Regulome in Lymphoblastoid Cells.
Jiang S; Zhou H; Liang J; Gerdt C; Wang C; Ke L; Schmidt SCS; Narita Y; Ma Y; Wang S; Colson T; Gewurz B; Li G; Kieff E; Zhao B
Cell Host Microbe; 2017 Oct; 22(4):561-573.e4. PubMed ID: 29024646
[TBL] [Abstract][Full Text] [Related]
39. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.
Zhang S; Pei Y; Lang F; Sun K; Singh RK; Lamplugh ZL; Saha A; Robertson ES
PLoS Pathog; 2019 Jan; 15(1):e1007514. PubMed ID: 30615685
[TBL] [Abstract][Full Text] [Related]
40. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation.
Jha HC; Shukla SK; Lu J; Aj MP; Banerjee S; Robertson ES
Oncotarget; 2015 Oct; 6(30):30115-29. PubMed ID: 26336822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
